Metabolism of acetylneurotensin(8-13) by proteolytic activities of intestinal enterocytes.
Bai
J P
JP
College of Pharmacy, University of Minnesota, Minneapolis 55455, USA.
Chang
L L
LL
D000595:Amino Acid Sequence; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D003600:Cytosol / Q000201:enzymology; D004355:Drug Stability; D007408:Intestinal Absorption / Q000187:drug effects; D007422:Intestines / Q000166:cytology / Q000201:enzymology*; D008297:Male; D008871:Microvilli / Q000201:enzymology; D008969:Molecular Sequence Data; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009496:Neurotensin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D010446:Peptide Fragments / Q000378:metabolism* / Q000493:pharmacokinetics; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000806:Angiotensin-Converting Enzyme Inhibitors; D010446:Peptide Fragments; D009496:Neurotensin; C034659:acetylneurotensin (8-13); D007703:Peptidyl-Dipeptidase A; D015260:Neprilysin